Flex Conference (Physical / Digital)

International Symposium on Oncology, Immunotherapy and Biomarkers - (ISOIB-27)

3rd - 4th March 2027 , Warsaw - Poland

Registration Options →

Access Flexible Participation Categories

Call For Papers

The (ISOIB-27) emphasizes interdisciplinary collaboration by bringing together experts from diverse fields. It encourages research that integrates multiple perspectives to address complex global challenges.

Key areas such as Oncology are explored to promote cross-domain knowledge exchange and collaborative innovation.

Authors are invited to submit papers addressing, but not limited to, the following areas:

  • Biomarkers in cancer diagnosis and treatment
  • Immunotherapy and its clinical applications
  • Role of precision medicine in oncology
  • Emerging trends in cancer immunotherapy
  • Biomarker discovery and validation
  • Challenges in immunotherapy implementation
  • Patient selection for immunotherapy
  • Combination therapies with immunotherapy
  • Ethical issues in biomarker research
  • Impact of biomarkers on treatment outcomes
  • Innovative technologies in biomarker analysis
  • Clinical trials for immunotherapeutic agents
  • Role of the immune system in cancer
  • Biomarkers for early cancer detection
  • Patient perspectives on immunotherapy
  • Regulatory considerations for biomarker use
  • Future directions in immunotherapy research
  • Collaboration between academia and industry
  • Health disparities in access to immunotherapy
  • Integrating biomarkers into clinical practice

Assessment

All submissions will undergo peer review to ensure quality and interdisciplinary relevance. Accepted papers will be presented and considered for publication in journals and conference proceedings.

Registration

Registering for the conference provides access to keynote sessions, technical presentations, and networking opportunities with global experts.

Publication

Publishing through the conference enhances the visibility of your research and connects your work with a broader academic audience.